References
Arnsten, A.F. and Li, B.M. (2005) Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biological Psychiatry 57 (11): 1377–1384.
Berridge, K.C. (2007) The debate over dopamine's role in reward: The case for incentive salience. Psychopharmacology (Berl) 191 (3): 391–431.
Clatworthy, P.L. et al. (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. Journal of Neuroscience 29 (15): 4690–4696.
DAK. (2009) Gesundheitsreport 2009: Analyse der Arbeitsunfähigkeitsdaten. Schwerpunktthema Doping am Arbeitsplatz. Hamburg: DAK Forschung.
de Jongh, R., Bolt, I., Schermer, M. and Olivier, B. (2008) Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32 (4): 760–776.
Johnston, L.D., O'Malley, P.M., Bachman, J.G. and Schulenberg, J.E. (2005) Monitoring the Future National Survey Results on Drug Use, 1975–2004. Volume I and II: Secondary School Students and College Students and Adults Ages 19–45. Bethesda, MD: National Institute on Drug Abuse (NIH Publication Nos. 05-5727 and 05-5728).
Kahneman, D. (1973) Attention and Effort. Englewood Cliffs, NJ: Prentice-Hall.
Kapner, D.A. (2003) Recreational Use of Ritalin on College Campuses. Newton, MA: The Higher Education Center for Alcohol and Other Drug Prevention.
Kapner, D.A. (2008) Recreational Use of Ritalin on College Campuses. Newton, MA: The Higher Education Center for Alcohol and Other Drug Prevention.
Killgore, W.D., Rupp, T.L., Grugle, N.L., Reichardt, R.M., Lipizzi, E.L. and Balkin, T.J. (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44h of continuous wakefulness. Journal of Sleep Research 17 (3): 309–321.
Kumar, R. (2008) Approved and investigational uses of modafinil: An evidence-based review. Drugs 68 (13): 1803–1839.
Lanni, C. et al. (2008) Cognition enhancers between treating and doping the mind. Pharmacological Research 57 (3): 196–213.
Mattay, V.S. et al. (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12 (3): 268–275.
Mattay, V.S. et al (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences U S A 100 (10): 6186–6191.
McCabe, S.E., Knight, J.R., Teter, C.J. and Wechsler, H. (2005) Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 100 (1): 96–106.
Mehta, M.A., Owen, A.M., Sahakian, B.J., Mavaddat, N., Pickard, J.D. and Robbins, T.W. (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 20 (6): RC65.
Muller, U., Steffenhagen, N., Regenthal, R. and Bublak, P. (2004) Effects of modafinil on working memory processes in humans. Psychopharmacology (Berl) 177 (1–2): 161–169.
Randall, D.C., Shneerson, J.M. and File, S.E. (2005) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacology Biochemistry & Behavior 82 (1): 133–139.
Rasmussen, N. (2008) America's first amphetamine epidemic 1929–1971: A quantitative and qualitative retrospective with implications for the present. American Journal of Public Health 98 (6): 974–985.
Sussman, S., Pentz, M.A., Spruijt-Metz, D. and Miller, T. (2006) Misuse of ‘study drugs’: prevalence, consequences, and implications for policy. Substance Abuse Treatment, Prevention and Policy 1: 15.
Teter, C.J., McCabe, S.E., Cranford, J.A., Boyd, C.J. and Guthrie, S.K. (2005) Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 53 (6): 253–262.
Wesensten, N.J., Belenky, G., Kautz, M.A., Thorne, D.R., Reichardt, R.M. and Balkin, T.J. (2002) Maintaining alertness and performance during sleep deprivation: Modafinil versus caffeine. Psychopharmacology (Berl) 159 (3): 238–247.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quednow, B. Ethics of neuroenhancement: A phantom debate. BioSocieties 5, 153–156 (2010). https://doi.org/10.1057/biosoc.2009.13
Published:
Issue Date:
DOI: https://doi.org/10.1057/biosoc.2009.13